Abiopharma

🔍 Addesso Dominic James (Director)

Company: Enact Holdings, Inc. (ACT)

Report Date: 2026-06-18

Detailed Transactions and Holdings:

• Acquired 348 shares of Deferred Stock Units (Derivative)
  Date: 2026-06-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,068.98 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1
• Holds 9,293 shares of Deferred Stock Units (Derivative)
  Date: 2026-06-18 | Code: H | shares_owned_after: 9,293.00 | Footnotes: F1, F1, F1
• Holds 24,177 shares of Deferred Stock Units (Derivative)
  Date: 2026-06-18 | Code: H | shares_owned_after: 24,177.00 | Footnotes: F1, F1, F1
• Holds 20,650 shares of Deferred Stock Units (Derivative)
  Date: 2026-06-18 | Code: H | shares_owned_after: 20,650.00 | Footnotes: F1, F1, F1

Footnotes:

• F1: Deferred Stock Units become payable in shares of Common Stock one year after termination of service as a director.
• F2: Additional deferred stock units acquired pursuant to reinvestment terms under the director award agreement from a dividend paid on June 18, 2026, at $0.24 per share.